Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Kyverna Therapeutics, Inc. (KYTX)
Portfolio Pulse from
A class action lawsuit has been filed against Kyverna Therapeutics, Inc. (NYSE: KYTX) by Gainey McKenna & Egleston. The lawsuit, filed in the Northern District of California, targets those who acquired Kyverna securities from February 8, 2024, onwards, seeking damages under federal securities laws.
December 10, 2024 | 7:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kyverna Therapeutics, Inc. is facing a class action lawsuit filed by Gainey McKenna & Egleston. The lawsuit, filed in the Northern District of California, involves investors who acquired Kyverna securities from February 8, 2024, onwards, seeking damages under federal securities laws.
The announcement of a class action lawsuit typically has a negative impact on a company's stock price due to potential financial liabilities and reputational damage. The lawsuit is directly related to Kyverna's securities, making it highly relevant and important for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100